Mapping of a syndrome of X-linked thrombocytopenia with thalassemia to band Xp11-12: Further evidence of genetic heterogeneity of X-linked thrombocytopenia

Blood

Volumn 95, Issue 7, 2000, Pages 2262-2268

  Raskind, Wendy H ^a,b   Niakan, Kathy K ^a   Wolff, John ^a   Matsushita, Mark ^a   Vaughan, Ty ^a   Stamatoyannopoulos, George ^a   Watanabe, Chiaki ^a   Rios, Jacinda ^a   Ochs, Hans D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ARTICLE; CHROMOSOME XP; CONTROLLED STUDY; GENE INACTIVATION; GENE LOCATION; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC RECOMBINATION; HAPLOTYPE; HUMAN; HUMAN CELL; MALE; MARKER GENE; PEDIGREE; PRIORITY JOURNAL; THALASSEMIA; THROMBOCYTOPENIA; X CHROMOSOME LINKAGE;

EID: 0034177890     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.7.2262     Document Type: Article

References (80)

1. Thompson AR, Wood WG, Stamatoyannopoulos G. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood. 1997;50:303.
2. Online Medelian Inheritance in Man (OMIM). Available at: http://www.ncbi.nlm.nih.gov/Omim. Accessed June 30, 1999.
3. Dib C, Faure S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 1996;380:152.
4. Auricchio A, Brancolini V, Casari G, et al. The locus for a novel syndromic form of neuronal intestinal pseudoobstruction maps to Xq28. Am J Hum Genet. 1996;58:743.
5. Pollock I, Holmes SJK, Patton MA, Hamilton PA, Stacey TE. Congenital intestinal pseudo-obstruction associated with a giant platelet disorder. J Med Genet. 1991;28:495.
6. FitzPatrick DR, Strain L, Thomas AE, et al. Neurogenic chronic idiopathic intestinal pseudo-obstruction, patent ductus arteriosus, and thrombocytopenia segregating as an X linked recessive disorder. J Med Genet. 1997;34:666.
7. Davidson HR, Connor JM. Dyskeratosis congenita. J Med Genet. 1988;25:843.
8. Reichel M, Grix AC, Isseroff RR. Dyskeratosis congenita associated with elevated fetal hemoglobin, X-linked ocular albinism, and juvenile-onset diabetes mellitus. Pediatr Derm. 1992;9:103.
9. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32.
10. Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291.
11. Rosse WF. Paroxysmal nocturnal hemoglobinuria: the biochemical defects and the clinical syndrome [review]. Blood. 1989;3:192.
12. Miyata T, Takeda J, Iida Y, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993;259:1318.
13. Mahoney JF, Urakaze M, Hall S, et al. Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. Blood. 1992;79:1400.
14. Hirose S, Ravi L, Prince GM, et al. Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A. 1992;89:6025.
15. Rosse WF. The glycolipid anchor of membrane surface proteins. Semin Hematol. 1993;30:219.
16. Notarangelo L, Parolini O, Faustini R, Porteri V, Albertini A, Ugazio A. Presentation of Wiskott-Aldrich syndrome as isolated thrombocytopenia. Blood. 1991;77:1125.
17. Standen G. Wiskott-Aldrich syndrome: a multidisciplinary disease. J Clin Pathol. 1991;44:979.
18. Derry JM, Kerns JA, Weinberg KI, et al. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum Mol Genet. 1995;4:1127.
19. Kolluri R, Shehabeldin A, Peacocke M, et al. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum Mol Genet. 1995;4:1119.
20. Villa A, Notarangelo L, Macchi P, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9:414.
21. Zhu Q, Zhang M, Blaese RM, et al. The Wiskott-Aldrich syndrome and X-linked thrombocytopenia are caused by mutations of the same gene. Blood. 1995;86:3797.
22. Zhu Q, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997;90:2680.
23. Ochs H. The Wiskott-Aldrich syndrome. Semin Hematol. 1998;35:332.
24. Raskind WH, Conrad EU, Chansky H, Matsushita M. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet. 1995;56:1132.
25. Zhu Q, Zhang M, Rawlings DJ, et al. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinema (XLA). J Exp Med. 1994;180:461.
26. Sarkar G, Yoon H-S, Sommer SS. Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations. Genomics. 1992;13:441.
27. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HnaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51:1229.
28. Lathrop GM, Lalouel JM, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984;81:3443.
29. Schaffer AA, Gupta K, Shriram K, Cottingham RW. Avoiding recomputation in linkage analysis. Hum Hered. 1994;44:225.
30. GENOME DATABASE (GDB) [database online]. Available at: http://www.gdb.org.
31. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet. 1998;63:861.
32. Comprehensive Human Genetic Maps. Available at: http://www.marshmed.org/genetics.
33. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics. 1990;6:575.
34. Gartler SM, Dyer KA, Goldman MA. Mammalian X chromosome inactivation. Mol Genet Med. 1992;2:121.
35. Yoshioka M, Yorifuji T, Mituyoshi I. Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy. Clin Genet. 1998;53:102.
36. Parolini O, Ressmann G, Haas OA, et al. X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med. 1998;338:291.
37. Tanner SM, Orstavik KH, Kristiansen M, et al. Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother. Hum Genet. 1999; 104:249.
38. Plenge RM, Hendrich BD, Schwartz C, et al. A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation. Nat Genet. 1997;17:353.
39. Gealy WJ, Dwyer JM, Harley JB. Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich carrier. Lancet. 1980;1:63.
40. Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM. Carrier detection in the Wiskott-Aldrich syndrome. Blood. 1988;56:1735.
41. Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics. 1989;4:60.
42. Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood. 1995;85:2471.
43. Ariga T, Yamada M, Wada T, Saitoh S, Sakiyama Y. Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome. Br J Haematol. 1999;104:893.
44. Puck JM, Siminovitch KA, Poncz M, Greenberg CR, Rottem M, Conley ME. Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation. Blood. 1990;75: 2369.
45. De Saint-Basile G, Schlegel N, Caniglia M, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers. Ann Hematol. 1991;63:107.
46. Belmont JW. Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet. 1996;58:1101.
47. Migeon BR. Non-random X chromosome inactivation in mammalian cells. Cytogenet Cell Genet. 1998;80:142.
48. Migeon BR, Haisley-Royster C. Familial skewed X inactivation and X-linked mutations: unbalanced X inactivation is a powerful means to ascertain X-linked genes that affect cell proliferation. Am J Hum Genet. 1998;62:1555.
49. McGrath JA. Dyskeratosis congenita: new clinical and molecular insights into ribosome function. Lancet. 1999;353:1204.
50. Saraste M, Hyvönen M. Pleckstrin homology domains: A fact file. Curr Opin Struct Biol. 1995;5: 403.
51. Hyvönen M, Macias MJ, Nilges M, Oschkinat H, Saraste M, Wilmanns M. Structure of the binding site for inositol phosphates in a PH domain. EMBO J 1995;14:4676.
52. Haffner C, Jarchau T, Reinhard M, et al. Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP. EMBO J. 1995;14:19.
53. Reinhard M, Giehl K, Abel K, et al. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J. 1995;14: 1583.
54. Symons M, Derry JM, Karlak B, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996;84:723.
55. Aspenstrom P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol. 1996;6:70.
56. Miki H, Nonoyama S, Zhu Q, Aruffo A, Ochs HD, Takenawa T. Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. Cell Growth Differ. 1997;8:195.
57. Forget GB. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci. 1998;850:38.
58. Boyer SH, Dover GJ, Serjeant GR, et al. Production of F cells in sickle cell anemia regulation by a genetic locus or loci separate from the beta-globin gene cluster. Blood. 1984;64:1053.
59. Miyoshi K, Kaneto Y, Kawai H, et al. X-linked dominant control of F-cells in normal adult life: characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on the X chromosome. Blood. 1988;72:1854.
60. Seltzer WK, Abshire TC, Lane PA, Roloff JS, Githens JH. Molecular genetic studies in black families with sickle cell anemia and unusually high levels of fetal hemoglobin. Hemoglobin. 1992;16:363.
61. Dover GJ, Smith KD, Chang YC, et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood. 1992;80:816.
62. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ. An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age. Blood. 1995;85:1111.
63. Deisseroth A, Nienhuis A, Turner P, et al. Localization of the human alpha globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell. 1977;12:205.
64. Gibbons RJ, Picketts DJ, Villard L, Higgs DR. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell. 1995;80:837.
65. Ellis NA. DNA helicases in inherited human disorders. Curr Opin Genet Dev. 1997;7:354.
66. Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OWJ, Gibbons RJ. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet. 1996;5:1899.
67. Gyapay G, Schmitt K, Fizames C, et al. A radiation hybrid map of the human genome. Hum Mol Genet. 1996;5:339.
68. Schwartz AL, Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med, 1999;50:57.
69. Swanson, DA Freund CL, Ploder L, McInnes RR, Valle D. A ubiquitin C-terminal hydrolase gene on the proximal short arm of the X chromosome: implications for X-linked retinal disorders. Hum Mol Genet. 1996;5:533.
70. Handley PM, Mueckler M, Siegel NR. Ciechanover A, Schwartz AL. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc Nat Acad Sci. U S A 1991;88:258.
71. Zacksenhaus E, Sheinin R. Molecular cloning of human A1S9 locus: an X-linked gene essential for progression through S phase of the cell cycle. Somat Cell Mol Genet. 1989;15:545.
72. Meyerson M, Enders GH, Wu C-L, et al. A family of human cdc2-related protein kinases. EMBO J. 1992;11:2909.
73. Carrel L, Clemson CM, Dunn JM, et al. X inactivation analysis and DNA methylation studies of the ubiquitin activating enzyme E1 and PCTAIRE-1 genes in human and mouse. Hum Mol Genet. 1996;5:391.
74. Huebner K, Isobe M, Gasson JC, Golde DW, Croce CM. Localization of the gene encoding erythroid-potentiating activity to chromosome region Xp11.1-Xp11.4. Am J Hum Genet. 1986;38: 819.
75. Knight JC, Grimaidi G, Thiesen HJ, Bech-Hansen NTM, Coleman MP. Clustered organization of Kruppel zinc-finger genes at Xp11.23, flanking a translocation breakpoint at OATL1: a physical map with locus assignments for ZNF21, ZNF41, ZNF81 , and ZLK1. Genomics. 1994;21:180.
76. Cook T, Gebelein B, Urrutia R. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann NY Acad Sci. 1999;880:94.
77. Marin M, Karis A, Visser P, Grosveld F, Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 1997;89:619.
78. Shivdasani RA, Fujiware Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;6:3965.
79. Wolffe AP. Histone deacetylase: a regulator of transcription. Science. 1996;272:371.
80. Grozinger CM, Hassig CA, Schreiber SL. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A. 1999;96:4868.